On December 1, Deputy Chief of Mission Joel Maybury and USAID Health Office Director Jessica Healey joined the Super Morning Show on LBS Radio to discuss the ongoing 16 Days of Activism Against Gender-based Violence campaign and World AIDS Day. They join the diplomatic community, the Government of Liberia, and civil society organizations in observing the 16 Days campaign and calling for an end to gender-based violence (GBV).
President Biden and Secretary of State Antony Blinken have clearly stated that achieving and protecting human rights for all remains a top goal for the United States. Preventing and responding to GBV is a human rights imperative and one that we are committed to championing.
Even before the COVID-19 pandemic, GBV impeded women and girls’ free and full participation in society. The pandemic has only exacerbated existing gender inequities, including increasing women’s economic insecurity; decreasing access to education and safe spaces for girls; and growing risk to all forms of GBV, particularly intimate partner violence, female genital mutilation/cutting, homophobic and transphobic violence, and child, early, and forced marriage.
In Liberia, promoting gender equity and equality is part of everything we do, including but certainly not limited to supporting women entrepreneurs, working with women to fully participate in the electoral cycle, promoting female recruitment and support in the security sector, investing heavily in education for girls, ensuring gender parity of reporters at press events, and contributing tens of millions of dollars to strengthening health systems in order for Liberian women and girls to lead healthy, productive, and fulfilling lives.
Deputy Chief of Mission Maybury, speaking to host Sorbor George, said that “Everyone deserves to live a life free from violence and achieve their full potential. Gender-based violence undermines the human rights and fundamental freedoms of far too many people in far too many places. By supporting women and girls, Liberia will see amazing benefits, including in economic well-being, health, and security.”
USAID Health Office Director Healey spoke about how the United States, through the President’s Emergency Program for AIDS Relief (PEPFAR), is assisting Liberia in achieving sustained epidemic control of HIV by supporting equitable health services, strengthening the national?health system?and capabilities, and?through our enduring collaboration with the Ministry of Health and civil society organizations.
The PEPFAR-Liberia country program is led by USAID, the U.S. Department of Defense, and our Health Resources and Services Administration office. The U.S. Government plans on spending US$10 million dollars across all our agencies next year to address HIV and AIDS issues in Liberia.
Last year, PEPFAR supported over 13,500 people living with HIV in Liberia with high quality treatment services. Our goal for this year is to almost double that and support over 22,000 people. This represents more than 50 percent of the total number of persons living with HIV in Liberia.
In partnership with the Government of Liberia and the Global Fund, our aim is to achieve HIV epidemic control in Liberia by 2030. This will necessitate equitable, person-centered services that respect the dignity and rights of all those who put their trust in us, particularly the most vulnerable. Ending GBV is a crucial part of this process. Together, we can address both these important issues and build a better future for Liberian women and men alike.
Distributed by APO Group on behalf of U.S. Embassy in Liberia.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
